Joe Rogan Experience #2469 - Brigham Buhler - Summary

Joe Rogan Experience #2469 - Brigham Buhler
PowerfulJRE · Watch on YouTube · Generated with SnapSummary · 2026-03-18

00:01 - Introduction to Joe Rogan Podcast ️
01:36 - FDA, Peptides, and Policy Discussion
06:45 - Testosterone, Prostate Cancer Myths, and Medical Dogma
15:04 - Peptides, Safety, and Regulatory Challenges
18:00 - GLP-1s, Celebrities, and Off-Label Prescribing
20:16 - Big Pharma Influence and the Compounding Debate
30:07 - Questioning Authority & Peptide Patents
31:23 - Problems with the Traditional Healthcare System
33:11 - Preventative Care, Longevity Tech & Patient-First Vision
45:07 - Challenges and Bad Actors in the Emerging Market ️
47:08 - HIMS, Novo Nordisk Deal and Regulatory Backlash
51:19 - Building a Life Raft: Alternatives, Regulation, and the Future of Biologics
1:00:08 - The Wild West of Peptides
1:02:22 - Redatride and Regulatory Enforcement
1:05:54 - Restoring Oversight: State vs Federal Action ️
1:15:10 - State-level momentum for peptides and biologics
1:16:04 - Medical tourism, cash-pay models, and patient autonomy ️
1:25:54 - Scaling concierge care with AI, genetics, and integrated apps
1:30:11 - Gene sequencing and app integration
1:32:58 - Gordon Ryan's genetic profile: strengths and vulnerabilities
1:34:56 - Future of personalized medicine and gene editing
1:45:12 - Genes & Predisposition Discussion
1:47:50 - Introduction to Muse Stem Cells
1:51:01 - Muse Cell Properties & Therapeutic Potential
2:00:13 - Muse cells as targeted regenerative therapy
2:02:41 - Age, diabetes, and mitochondrial effects of Muse cells
2:06:04 - Clinical successes, regulatory challenges, and plasma apheresis ️
2:15:15 - Plasma exchange explained
2:16:53 - Microplastics case study and results
2:19:54 - Challenges of multi-modality treatments

Summarize any YouTube video instantly